Cargando…
Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design
Designing optimal (neo)adjuvant therapy is a crucial aspect of the treatment of non-small-cell lung carcinoma (NSCLC). Standard methods of chemotherapy, radiotherapy, and immunotherapy represent effective strategies for treatment. However, in some cases with high metastatic activity and high levels...
Autores principales: | Kejík, Zdeněk, Kaplánek, Robert, Dytrych, Petr, Masařík, Michal, Veselá, Kateřina, Abramenko, Nikita, Hoskovec, David, Vašáková, Martina, Králová, Jarmila, Martásek, Pavel, Jakubek, Milan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619417/ https://www.ncbi.nlm.nih.gov/pubmed/34834295 http://dx.doi.org/10.3390/pharmaceutics13111879 |
Ejemplares similares
-
Iron Complexes of Flavonoids-Antioxidant Capacity and Beyond
por: Kejík, Zdeněk, et al.
Publicado: (2021) -
New-Generation Heterocyclic Bis-Pentamethinium Salts as Potential Cytostatic Drugs with Dual IL-6R and Mitochondria-Targeting Activity
por: Talianová, Veronika, et al.
Publicado: (2022) -
Targeting of the Mitochondrial TET1 Protein by Pyrrolo[3,2-b]pyrrole Chelators
por: Antonyová, Veronika, et al.
Publicado: (2022) -
Estrogen Receptor Modulators in Viral Infections Such as SARS−CoV−2: Therapeutic Consequences
por: Abramenko, Nikita, et al.
Publicado: (2021) -
Diagnosis and Surgical Management of Insulinomas—A 23-Year Single-Center Experience
por: Hoskovec, David, et al.
Publicado: (2023)